Regulatory News: Following an R&D phase lasting more than 30 months, Groupe Berkem (ISIN: FR00140069V2 Ticker: ALKEM) (Paris:ALKEM) a specialist in integrating plant-based chemistry into everyday
Regulatory News: Groupe Berkem, a leading player in bio-based chemicals (ISIN code: FR00140069V2 Ticker: ALKEM), announced that the Annual Shareholder's Meeting of the Company will be held on Friday
Highly successful IPO on the Euronext Growth market in Paris Strong growth of 14% in 2021 revenue to €46.1 million and EBITDA margin of 20% Very encouraging start to 2022, with first-quarter revenue
Commercialization of 100% bio-based alkyd resins: an unprecedented innovation on the paints market Products that are competitive with conventional products, essential given the substantial
2024 financial targets reaffirmed: Annual revenue of €65 million, which could be increased to at least €85 million if M&A operations are carried out EBITDA margin of approximately